发明申请
WO2017165886A1 INHIBITION OF CATALYTIC SITE COMMON TO MULTIPLE 3 ALPHA-OXIDOREDUCTASES FOR TREATMENT OF PROSTATE CANCER
审中-公开
催化部位对多种3种α氧化还原剂治疗前列腺癌的抑制作用
- 专利标题： INHIBITION OF CATALYTIC SITE COMMON TO MULTIPLE 3 ALPHA-OXIDOREDUCTASES FOR TREATMENT OF PROSTATE CANCER
- 专利标题（中）： 催化部位对多种3种α氧化还原剂治疗前列腺癌的抑制作用
-
申请号： PCT/US2017/024322申请日： 2017-03-27
-
公开(公告)号： WO2017165886A1公开(公告)日： 2017-09-28
- 发明人: MOHLER, James, L. , FIANDALO, Michael , WATT, David , WILSON, Elizabeth
- 申请人： HEALTH RESEARCH, INC.
- 申请人地址： Elm and Carlton Streets Buffalo, NY 14263 US
- 专利权人： HEALTH RESEARCH, INC.
- 当前专利权人： HEALTH RESEARCH, INC.
- 当前专利权人地址： Elm and Carlton Streets Buffalo, NY 14263 US
- 代理机构： WATT, Rachel S. et al.
- 优先权： US62/313,261 20160325
- 主分类号： A61K31/568
- IPC分类号： A61K31/568 ; C12Q1/26 ; C12Q1/32
摘要：
Methods and compositions which are directed against catalytic site common to multiple 3 αlpha-oxidoreductases. The compositions can be used for the treatment of prostate cancer.
